Template:Cryptococcus Pneumonia: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
*Fluconazole 400mg PO IV q24hrs x 6-12 months '''OR''' | *Fluconazole 400mg PO IV q24hrs x 6-12 months '''OR''' | ||
*Itraconazole 200mg PO q12hrs daily x 6-12 months '''OR''' | *Itraconazole 200mg PO q12hrs daily x 6-12 months '''OR''' | ||
*Voriconazole 200mg PO q12hrs x 6-12 months | *Voriconazole 200mg PO q12hrs x 6-12 months | ||
===Pulmonary (with AIDS)=== | ===Pulmonary (with AIDS)=== | ||
*Fluconazole 400mg PO q24hrs x 6-12 months | *Fluconazole 400mg PO q24hrs x 6-12 months | ||
Revision as of 06:38, 6 March 2019
Pulmonary (not AIDs associated)
- Fluconazole 400mg PO IV q24hrs x 6-12 months OR
- Itraconazole 200mg PO q12hrs daily x 6-12 months OR
- Voriconazole 200mg PO q12hrs x 6-12 months
Pulmonary (with AIDS)
- Fluconazole 400mg PO q24hrs x 6-12 months